会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明公开
    • 손상 조직의 기능적 재생 촉진용 의약
    • 用于促进损伤组织功能再生的药物
    • KR1020090078304A
    • 2009-07-17
    • KR1020087018560
    • 2007-10-30
    • 가부시키가이샤 제노믹스고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸
    • 다마이가츠토야마자키다케히코가네다야스후미
    • A61K38/00A61K48/00A61K31/711A61P17/00
    • A61K31/711A61K38/00C07K14/52G01N33/5073G01N33/6863G01N2500/10A61K38/17A61K48/00
    • The present inventors revealed for the first time in the world that 1) a large amount of bone marrow-derived cells are mobilized in transplanted skin; 2) the mobilized bone marrow-derived cells are differentiated into any of dermal fibroblasts, adipocytes, muscle cells, vascular endothelial cells and epidermal keratinocytes in a transplanted skin graft, and in the mobilized bone marrow-derived cells, bone marrow-derived mesenchymal stem cells are contained; 3) what mobilize the bone marrow-derived mesenchymal stem cells to the graft from the peripheral blood are HMGB1, HMGB2 and HMGB3 released from necrotic tissue of the transplanted skin; 4) purified HMGB1, HMGB2 and HMGB3 promote migration of mesenchymal stem cells isolated from the bone marrow and cultured; 5) active substances including HMGB1 that allow bone marrow mesenchymal stem cells to migrate can be simply purified from an extract of a large number of organs including skin, brain and heart; 6) active substances that allow bone marrow mesenchymal stem cells to migrate can be simply extracted from cultured cells; and 7) a heparin column-purified fraction of skin extract mobilizes a large amount of bone marrow-derived cells during brain damage.
    • 本发明人首次透露,1)大量的骨髓来源的细胞被移植到移植的皮肤中; 2)移植的骨髓来源的细胞被分化成移植的皮肤移植物中的任何真皮成纤维细胞,脂肪细胞,肌肉细胞,血管内皮细胞和表皮角质形成细胞,并且在动员的骨髓来源的细胞中,骨髓来源的间充质干细胞 包含细胞; 3)从外周血移植骨髓间充质干细胞移植HMGB1,HMGB2和HMGB3从移植皮肤的坏死组织中释放出来; 4)纯化的HMGB1,HMGB2和HMGB3促进从骨髓​​分离的间充质干细胞的迁移并培养; 5)允许骨髓间充质干细胞迁移的包括HMGB1的活性物质可以从包括皮肤,脑和心脏在内的大量器官的提取物中简单纯化; 6)允许骨髓间充质干细胞迁移的活性物质可以简单地从培养细胞中提取; 和7)皮肤提取物的肝素柱纯化部分在脑损伤期间动员大量骨髓来源的细胞。